Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo.

von Willebrand factor (vWF) is frequently used as a biochemical marker for endothelial cells (ECs). Despite this, little is known about the relative level of expression and regulation of this hemostatic factor in ECs in different vascular beds in vivo. In the present study, we used quantitative reverse transcription polymerase chain reaction and in situ hybridization analysis to study vWF gene expression in murine tissues. Large differences in the level of vWF mRNA were observed when comparing highly vascularized tissues, with the lung and brain containing 5 to 50 times higher concentrations of vWF mRNA than the kidney and liver. In this regard, ECs of small vessels and some microvessels in the lung and brain expressed abundant vWF mRNA, whereas ECs of similar sized vessels in the liver and kidney expressed relatively low levels. In general, significantly higher levels of vWF mRNA and antigen were demonstrated in ECs of larger vessels compared with microvessels and in venous ECs compared with arterial ECs. Although intraperitoneal administration of endotoxin (or tumor necrosis factor-alpha) increased plasma vWF levels, it had variable effects on the steady-state level of vWF mRNA in murine tissues (ie, it decreased vWF mRNA in many tissues, increased it in others, and had little effect on still others). These results indicate that vWF is differentially expressed and regulated in ECs present in different tissues and within the same vascular bed.

[1]  W. Aird,et al.  Vascular Bed–specific Expression of an Endothelial Cell Gene Is Programmed by the Tissue Microenvironment , 1997, The Journal of cell biology.

[2]  Z. Ruggeri Mechanisms Initiating Platelet Thrombus Formation , 1997, Thrombosis and Haemostasis.

[3]  K. Osborn,et al.  The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location. , 1997, Journal of cell science.

[4]  J. T. ten Cate,et al.  Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. , 1996, Blood.

[5]  D. Loskutoff,et al.  Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. , 1996, The Journal of clinical investigation.

[6]  Brian Savage,et al.  Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor , 1996, Cell.

[7]  D. Loskutoff,et al.  Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. , 1996, The Journal of clinical investigation.

[8]  K. Cooney,et al.  von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. , 1995, Blood.

[9]  K. Cooney,et al.  von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene [published erratum appears in Blood 1995 Sep 15;86(6):2461] , 1994 .

[10]  N. Mackman,et al.  Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. , 1993, The American journal of pathology.

[11]  D. Lakich,et al.  Sequence of the murine factor VIII cDNA. , 1993, Genomics.

[12]  Y. Eguchi,et al.  Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. , 1993, The American journal of pathology.

[13]  J. Sadler von Willebrand factor. , 1991, The Journal of biological chemistry.

[14]  D. Monard,et al.  Prothrombin mRNA is expressed by cells of the nervous system , 1991, Neuron.

[15]  K Watanabe,et al.  The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. , 1991, The Journal of clinical investigation.

[16]  H. Weiss von Willebrand Factor and Platelet Function a , 1991, Annals of the New York Academy of Sciences.

[17]  H. Büller,et al.  Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. , 1990, Blood.

[18]  J. Parrillo,et al.  Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. , 1989, The New England journal of medicine.

[19]  L. Coulombel,et al.  Expression of von Willebrand factor in porcine vessels: Heterogeneity at the level of von Willebrand factor mRNA , 1989, Journal of cellular physiology.

[20]  D. Baruch,et al.  von Willebrand factor and platelet function. , 1989, Bailliere's clinical haematology.

[21]  M. Dougados,et al.  Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis. , 1988, The Journal of laboratory and clinical medicine.

[22]  Eugene C. Butcher,et al.  A tissue-specific endothelial cell molecule involved in lymphocyte homing , 1988, Nature.

[23]  J D Hellums,et al.  Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. , 1988, Blood.

[24]  A. Schorer,et al.  Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells , 1987, British journal of haematology.

[25]  V. Fuster,et al.  Distribution of von Willebrand Factor in Porcine Intima Varies with Blood Vessel Type and Location , 1987, Arteriosclerosis.

[26]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[27]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[28]  R. Auerbach,et al.  Heterogeneity of Mouse Vascular Endothelium , 1987 .

[29]  C. Rothschild,et al.  Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. , 1987, Arteriosclerosis.

[30]  R. Auerbach,et al.  Heterogeneity of mouse vascular endothelium. In vitro studies of lymphatic, large blood vessel and microvascular endothelial cells. , 1987, Blood vessels.

[31]  C. Esmon,et al.  Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. , 1987, The Journal of clinical investigation.

[32]  D. Wagner,et al.  Inducible secretion of large, biologically potent von Willebrand factor multimers , 1986, Cell.

[33]  D. Fass,et al.  Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. , 1986, The Journal of clinical investigation.

[34]  D. Meyer,et al.  Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies. , 1985, Blood.

[35]  R. Lawn,et al.  Distribution of factor VIII mRNA and antigen in human liver and other tissues , 1985, Nature.

[36]  Johnson Cm,et al.  Porcine cardiac valvular endothelial cells in culture. A relative deficiency of fibronectin synthesis in vitro. , 1983 .

[37]  T. H. van der Kwast,et al.  Detection of factor VIII/coagulant antigen in human liver tissue , 1983, Nature.

[38]  A. Bloom,et al.  Differential localisation and synthesis of porcine factor VIII related antigen (VIIIR:AG) in vascular endothelium and in endothelial cells in culture. , 1983, Thrombosis research.

[39]  J. Pearson,et al.  Prostacyclin release stimulated by thrombin or bradykinin in porcine endothelial cells cultured from aorta and umbilical vein. , 1983, Thrombosis research.

[40]  D. Fass,et al.  Porcine cardiac valvular endothelial cells in culture. A relative deficiency of fibronectin synthesis in vitro. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[41]  E. Tuddenham,et al.  Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease , 1982, British journal of haematology.

[42]  D. Wagner,et al.  Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells , 1982, The Journal of cell biology.

[43]  C. Kisker,et al.  Thrombin - endothelial cell interactions: critical importance of endothelial cell vessel of origin. , 1982, Thrombosis research.

[44]  E. Jaffe,et al.  Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. , 1977, The Journal of clinical investigation.

[45]  E. Jaffe,et al.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells. , 1973, The Journal of clinical investigation.